Bristol-Myers Squibb Announces Closing of Its Barceloneta, Puerto Rico Plant
The decision to cease operations at the site aligns with the company's transformation to a biopharmaceutical company and its continuous improvement efforts aimed at enhancing the company's efficiency, effectiveness and competitiveness as it improves its cost base.
"As a biopharmaceutical company focused on growth areas, such as specialty medicines and biologics, we are committed to optimizing our global manufacturing network to ensure we meet the pipeline needs of the company and position Bristol-Myers Squibb for strong long-term growth and success," said Carlo de Notaristefani, president of Technical Operations.
The Bristol-Myers Squibb Barceloneta plant commenced operations in 1970. Operations will be phased out through 2008. The closure of the site will impact approximately 225 individuals. The company will continue to have a presence in Puerto Rico with manufacturing operations in Humacao and Manati.
Other news from the department manufacturing
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.